- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00438542
HMW-Adiponectin is Raised in Newborns
February 21, 2007 updated by: University of Oslo
Cross sectional, hospital-based study dealing with adiponectin levels in newborns to mothers with pre-eclampsia.
Venus cord blood samples were collected immediately after birth; 30 cases and 62 controls were enrolled into the study.
The study was approved by the local ethics committee and all participants gave written consent.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 30 minutes (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Pre-eclampsia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Lars Morkrid, MD, PhD, Institute of Clinical Chemistry, Medical Faculty, University of Oslo, Norway
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2003
Study Completion
July 1, 2006
Study Registration Dates
First Submitted
February 21, 2007
First Submitted That Met QC Criteria
February 21, 2007
First Posted (ESTIMATE)
February 22, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
February 22, 2007
Last Update Submitted That Met QC Criteria
February 21, 2007
Last Verified
February 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HMWadpkcb
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pre-Eclampsia
-
University Tunis El ManarCompleted
-
Amsterdam UMCZonMw: The Netherlands Organisation for Health Research and DevelopmentNot yet recruitingPre-Eclampsia | HELLP Syndrome | Pre-eclampsia or Eclampsia With Pre-existing Hypertension | HELLP | Pre-Eclampsia; Complicating Pregnancy | Pre-Eclampsia Onset Less Than 37 Weeks | Pre-Eclampsia as Antepartum Condition | Pre-Eclampsia; Affecting Fetus | HELLP Syndrome Complicating Pregnancy
-
Dow University of Health SciencesCompletedPre-eclampsia | Hypertension, Pregnancy Induced | Hydralazine Adverse Reaction | Pre-eclampsia Superimposed Pre-existing HypertensionPakistan
-
University of WashingtonUniversity of Cape TownCompletedSevere Pre-eclampsia | Mild Pre-eclampsiaSouth Africa, United States
-
Evergreen Therapeutics, Inc.Not yet recruiting
-
William Marsh Rice UniversityUniversity of MalawiCompleted
-
Duke UniversityTerminated
-
William Marsh Rice UniversityCompletedPre EclampsiaUnited States
-
Oxford University Hospitals NHS TrustUniversity of CambridgeTerminated
-
Novartis PharmaceuticalsTerminatedPre-eclampsiaItaly, United States